
DBD Stock Forecast & Price Target
DBD Analyst Ratings
Bulls say
Diebold Nixdorf Inc. has demonstrated a strong ability to capture market share, gaining five percentage points globally in 2023, particularly in the U.S., Europe, and Latin America, indicating a positive trend in its competitive position despite slight losses in Asia. The company's strategic refinancing is projected to enhance free cash flow (FCF) generation significantly, with an anticipated $70 million annual improvement driving the FCF forecast to between 40% and 50% of EBITDA by 2025, up from 25% currently. Additionally, ongoing investments into manufacturing capabilities in India and the resilient demand in the global ATM and self-checkout markets suggest a favorable outlook for revenue growth as the installed base is expected to increase significantly over the next several years.
Bears say
Diebold Nixdorf Inc faces a negative outlook primarily due to declining demand for its products and increasing competition, which is exerting pressure on pricing and margins. The company is also grappling with disruptions in its supply chain, which could hinder product shipments, installations, and overall service delivery. Furthermore, there are concerns regarding liquidity and the company's failure to satisfy debt service obligations, compounded by foreign exchange volatility that affects its revenue generation in key markets such as EMEA and the Americas.
This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.
DBD Analyst Forecast & Price Prediction
Start investing in DBD
Order type
Buy in
Order amount
Est. shares
0 shares